Peer Support in Alcohol Dependence
- Conditions
- Alcohol Use Disorder
- Interventions
- Behavioral: Quality life questionnaire AQoLSBehavioral: Quality life questionnaire Euroqol EQ-5D-5LOther: Peer support consultations
- Registration Number
- NCT06381609
- Lead Sponsor
- Hospices Civils de Lyon
- Brief Summary
Alcohol use disorder (AUD) affects between 4% and 6% of French adults, and requires appropriate medical treatment.
However, 20-40% of patients with AUD are lost to follow-up at an early stage. Consequently, it is important for addiction departments to implement and evaluate innovative tools and interventions, including the involvement of peer support, to help patients remain in care, and to assess whether peer support has a positive impact on their clinical outcome.
Addiction peer support specialists (APSSs) are individuals who have personally experienced addiction, and who have decided to use their experience to assist other people going through a similar situation, after completing a specific official graduation.
Compared to other caregivers, APSSs may induce in patients a sense of identification which could improve the patient motivation to engage and remain in care.
This is the main hypothesis and the main scientific objective of the PEERSIAD study, which will aim to confirm that accompanying patients with AUD using APSSs after alcohol detoxification, reduces the rate of lost-to-follow-up and improves the overall clinical outcome.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 626
- Aged ≥ 18
- Socially insured
- Meeting DSM-5 criteria for alcohol use disorder (AUD)
- Abstinent from alcohol and involved in supervised alcohol withdrawal for at least 5 days and no more than 21 days (outpatient or inpatient)
- Starting a post-detoxification outpatient program
- Other severe substance use disorder, i.e. DSM-5 criteria ≥ 6 (excluding tobacco)
- Patient under protective measure (safeguard measure, guardianship) or deprived of liberty or in ordered care and hospitalization measures without consent.
- Inability to communicate and express oneself orally in French, compromising the possibility of exchanges between the Peer support and the patient.
- Psychiatric or cognitive comorbidities making inclusion impossible, at the investigator's discretion.
- Individual accompaniment by a Peer support in the 15 days prior to inclusion.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Control Group Quality life questionnaire AQoLS 313 patients will be recruited over 3 years in the control group. Patients will receive "as usual" outpatient abstinence-maintenance follow-up, with consultations of all kinds (medical, psychological, nursing, group, etc.) Peer support Group Quality life questionnaire Euroqol EQ-5D-5L 313 patients will be recruited over 3 years in the peer support group. Patients will be accompanied by an addiction peer support specialist, as part of an "add-on" follow-up compared with conventional follow-up (same management as in the control group). Control Group Quality life questionnaire Euroqol EQ-5D-5L 313 patients will be recruited over 3 years in the control group. Patients will receive "as usual" outpatient abstinence-maintenance follow-up, with consultations of all kinds (medical, psychological, nursing, group, etc.) Peer support Group Quality life questionnaire AQoLS 313 patients will be recruited over 3 years in the peer support group. Patients will be accompanied by an addiction peer support specialist, as part of an "add-on" follow-up compared with conventional follow-up (same management as in the control group). Peer support Group Peer support consultations 313 patients will be recruited over 3 years in the peer support group. Patients will be accompanied by an addiction peer support specialist, as part of an "add-on" follow-up compared with conventional follow-up (same management as in the control group).
- Primary Outcome Measures
Name Time Method Unplanned cessation of care at 6 months At 6 months after inclusion The unplanned cessation of care at 6 months, excluding consultations with an APSS, with no further contact in the following month, is defined as having had a last planned consultation that was not fulfilled between M0 and M6
- Secondary Outcome Measures
Name Time Method average number of standard drinks declared per week At inclusion, 3 and 6 months after inclusion Euroqol-5D-5L questionnaire score At inclusion, 3 and 6 months after inclusion The differential cost-utility ratio, in relation to the innovative strategy including a Peer Support, will be assessed using the Euroqol-5D-5L questionnaire (EQ-5D-5L).
Difference in costs (in euros) At 1, 2 and 3 years after the beginning of implementation on French territory An additional analysis will be carried out if the cost-utility ratio is positive: Difference in costs (in euros) for the payer (French compulsory health insurance) between a scenario in which the innovative management is implemented and disseminated in practice and on French territory, and a scenario in which usual follow-up is maintained.
Alcohol Use Disorders Identification Test-Consumption (AUDIT-C) score At inclusion, 3 and 6 months after inclusion Montgomery-Åsberg Depression Rating Scale (MADRS) score At inclusion, 3 and 6 months after inclusion Changes in levels of depression will be measured using MADRS
type of psychostimulant use At inclusion, 3 and 6 months after inclusion State-Trait Anxiety Inventory (STAI-Y) score At inclusion, 3 and 6 months after inclusion Changes in levels of anxiety will be measured using STAI-Y
Cannabis Use Disorders Identification Test - Revised (CUDIT-R) score At inclusion, 3 and 6 months after inclusion Changes in the severity of cannabis use will be measured by the CUDIT-R score
frequency of opioid use At inclusion, 3 and 6 months after inclusion Health Care Satisfaction Questionnaire (HCSQ) score At 6 months after inclusion Patient's satisfaction will be measured by HCSQ questionnaire
Alcohol Quality of Life Scale (AQoLS) score At inclusion, 3 and 6 months after inclusion Changes in quality of life will be measured using the AQoLS
type of opioid use At inclusion, 3 and 6 months after inclusion frequency of psychostimulant use At inclusion, 3 and 6 months after inclusion Number of unfulfilled consultations 6 months after inclusion The number of unfulfilled consultations (scheduled consultations, excluding Peer Support consultations, without patient's visit with or without justification) over the 6-month study follow-up period, collected from the medical records of the addictology department.
Number of AUD criteria according to Diagnostic and Statistical Manual of Mental Disorders (DSM-5) At inclusion, 3 and 6 months after inclusion Fagerström test score At inclusion, 3 and 6 months after inclusion Tobacco use will be measured by the Fagerström test
Service organization description Before setting up of the study AIM score At 6 months after inclusion AIM score measured in patients
Adoption of intervention After last visit of last patient (around 3,5 years after first inclusion) adoption of intervention will be assessed through semi-structured interviews and measurement of the number of patients followed-up versus the number of eligible patients, refusals to be accompanied by APSS, and premature discontinuation of follow-up
Intervention fidelity After last visit of last patient (around 3,5 years after first inclusion) intervention fidelity will be assessed by monitoring APSS activity indicators, describing deviations from the protocol and semi-structured interviews
Number of hospitalisations At 6 months after inclusion Measurement of the number of hospitalisations related or not to the AUD and the ratio of total hospital days to number of hospital admissions (based on medical records and patient interviews)
Description of type of support and missions performed by Peer Support After last visit of last patient (around 3,5 years after first inclusion) Acceptability of Intervention Measure (AIM) score After last visit of last patient (around 3,5 years after first inclusion) AIM score measured in Peer Support and medical staff
Trial Locations
- Locations (5)
CH Le Vinatier
🇫🇷Bron, France
Bichat Hospital
🇫🇷Paris, France
CHS St Anne
🇫🇷Paris, France
GH Nord, Hospices Civils de Lyon
🇫🇷Lyon, France
Hôpital Beaujon
🇫🇷Clichy, France